Children With Aluminium Contact Allergy: Cutaneous Exposure Study
NCT04438135 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2022-04-08
Summary
Aluminium is used in many different cosmetic products, including make-up, deodorants and sunscreen. The purpose of this study is to investigate whether these everyday skin products with small amounts of aluminium can cause skin reactions in children diagnosed with contact allergy to aluminium.
The study is conducted as a Repeated Open Application Test study (ROAT), a method originally developed to clarify the clinical relevance of questionable and positive patch samples, by imitating everyday use of a skin product.
Conditions
- Contact Dermatitis
- Contact Allergy
- Aluminum Allergy
Interventions
- OTHER
-
Repeated open application test
parallel application of two different types of lotion with and without aluminium.
Sponsors & Collaborators
-
National Allergy Research Center, Denmark
lead OTHER
Principal Investigators
-
Jeanne Duus Johansen, Prof. · National Allergy Research Centre
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- OTHER
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 2 Years
- Max Age
- 10 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-06-10
- Primary Completion
- 2022-04-07
- Completion
- 2022-04-07
Countries
- Denmark
Study Locations
More Related Trials
-
The Immunological Profile of Nickel Dermatitis
NCT04438330 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
NCT00640250 ·Status: COMPLETED ·Phase: PHASE2
-
Detection of Aluminium-reactive T-lymphocytes in Patients With Vaccination Granulomas
NCT06130462 ·Status: COMPLETED ·Phase: NA
-
Allergic Disease Onset Prevention Study
NCT05003804 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
NCT01797562 ·Status: COMPLETED ·Phase: NA
-
Food-Specific and Component IgE Threshold Levels That Predict Food Allergy in People With Elevated Total Serum IgE Levels and Atopic Dermatitis
NCT03835767 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
NCT01518348 ·Status: WITHDRAWN ·Phase: PHASE3
-
Allergen Provocations- HCA Children's Hospital
NCT04331522 ·Status: RECRUITING
-
A Study to Assess the Biological Potency of Peanut Allergen Extract in Adolescent and Adult Peanut Allergic Subjects
NCT03352726 ·Status: COMPLETED ·Phase: PHASE1
-
Epidemiology and Co-Reactivity of Novel Surfactant Allergens
NCT02534441 ·Status: COMPLETED ·Phase: NA
-
Intervention Study to Evaluate the Importance of Information Given to Patients With Contact Allergy
NCT01953380 ·Status: COMPLETED ·Phase: NA
-
Effect of Vitamin C on Allergy Skin Test
NCT05810233 ·Status: UNKNOWN ·Phase: NA
-
Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
NCT02028208 ·Status: COMPLETED ·Phase: PHASE2
-
The Role of Interleukin-1 Beta Targeted Therapy for Patients Suffering From Allergic Contact Dermatitis
NCT05498467 ·Status: COMPLETED ·Phase: PHASE3
-
Immune Reactions in Contact Dermatitis Affected Skin
NCT01546298 ·Status: COMPLETED
-
Dermatological Assessment of Primary Dermal Irritability Accumulated and Sensitization
NCT04248556 ·Status: COMPLETED ·Phase: NA
-
Dermatological Assessment of Photoallergy and Phototoxicity
NCT04250623 ·Status: COMPLETED ·Phase: NA
-
Systemic Nickel Allergy Syndrome: Intervention Study for the Assessment of the Dietary Indications
NCT04432896 ·Status: COMPLETED ·Phase: NA
-
Dermatological Assessment of Primary Dermal Irritability Accumulated, Sensitization, Photoallergy and Phototoxicity.
NCT04332445 ·Status: COMPLETED ·Phase: NA
-
Serum Interleukin -21 Level in Patients With Severe Adverse Cutaneous Drug Reaction.
NCT03166241 ·Status: UNKNOWN ·Phase: NA
-
Understanding How the Immune System Responds to Viruses in Peanut Allergic Children Undergoing Peanut Oral Immunotherapy
NCT01074840 ·Status: COMPLETED ·Phase: NA
-
Adding a Short Burst of Corticosteroid to the Conventional Treatment of H1 Antihistamines in Emergency Department.
NCT03296358 ·Status: COMPLETED ·Phase: NA
-
Protocol of Reintroduction of Beta-lactams in Children at Low Risk of Anaphylaxis.
NCT03553251 ·Status: UNKNOWN
-
NI-0801 in Allergic Contact Dermatitis
NCT01244607 ·Status: COMPLETED ·Phase: PHASE1
-
Clinical Evaluation of T.R.U.E. TEST in Children and Adolescents
NCT00795951 ·Status: COMPLETED ·Phase: PHASE4